Psoriasis Clinical Trial

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Summary

The main objective of this study is to compare the effects of CP-690,550 with the effects of placebo in patients being treated for moderate to severe chronic plaque psoriasis. This one-year study will also evaluate the safety and tolerability of CP-690,550 versus placebo.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Are 18 years or older with diagnosis for at least 12 months of moderate to severe plaque psoriasis covering as least 10%of body surface area
a Psoriasis Area and Severity Index (PASI) score of 12 and are considered to be candidates for systemic or light therapy
No evidence of active or latent tuberculosis

Exclusion Criteria:

Non-plaque or drug induced forms of psoriasis
cannot discontinue current oral, injectible or topical therapy for psoriasis or cannot discontinue phototherapy (PUVA or UVB)
any uncontrolled significant medical condition

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

901

Study ID:

NCT01276639

Recruitment Status:

Completed

Sponsor:

Pfizer

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 66 Locations for this study

See Locations Near You

Radiant Research, Inc.
Birmingham Alabama, 35209, United States
University of California, Irvine - Dermatology Research
Irvine California, 92697, United States
Skin Surgery Medical Group, Inc.
San Diego California, 92117, United States
Clinical Science Institute
Santa Monica California, 90404, United States
Cherry Creek Research, Inc.
Denver Colorado, 80209, United States
The Savin Center, P.C.
New Haven Connecticut, 06511, United States
Renstar Medical Research
Ocala Florida, 34471, United States
Academic Alliance in Dermatology
Tampa Florida, 33609, United States
Atlanta Dermatology, Vein & Research Center, P.C.
Alpharetta Georgia, 30022, United States
Peachtree Dermatology Associates Research Center
Atlanta Georgia, 30327, United States
MedaPhase Inc.
Newnan Georgia, 30263, United States
Southern Illinois University School of Medicine
Springfield Illinois, 62702, United States
Dawes Fretzin Clinical Research Group, LLC
Indianapolis Indiana, 46256, United States
Tufts Medical Center
Boston Massachusetts, 02111, United States
Massachusetts General Hospital - Clinical Unit for Research Trials and Outcomes in Skin
Boston Massachusetts, 02114, United States
Skin Specialists, P.C.
Omaha Nebraska, 68144, United States
New York University School of Medicine
New York New York, 10016, United States
Skin Search of Rochester, Inc.
Rochester New York, 14623, United States
Raleigh Radiology Blue Ridge
Raleigh North Carolina, 27612, United States
Wake Research Associates
Raleigh North Carolina, 27612, United States
Central Sooner Research
Norman Oklahoma, 73071, United States
Baker Allergy, Asthma and Dermatology Research Center, LLC
Lake Oswego Oregon, 97035, United States
University of Pittsburgh Medical Center - Department of Dermatology
Pittsburgh Pennsylvania, 15213, United States
Clinical Partners, LLC
Johnston Rhode Island, 02919, United States
Dermatology Associates of Knoxville, PC
Knoxville Tennessee, 37917, United States
Modern Research Associates, PLLC
Dallas Texas, 75231, United States
Menter Dermatology Research Institute
Dallas Texas, 75246, United States
Center for Clinical Studies
Houston Texas, 77030, United States
Rockwood Dermatology Center
Spokane Washington, 99202, United States
Rockwood Research Center
Spokane Washington, 99202, United States
Wenatchee Valley Medical Center - Clinical Research Department
Wenatchee Washington, 98801, United States
Madison Skin and Research, Inc.
Madison Wisconsin, 53719, United States
Dermadvances Research
Winnipeg Manitoba, R3C 1, Canada
Dr. Zohair Tomi PMC Inc.
St. John's Newfoundland and Labrador, A1B 4, Canada
Eastern Canada Cutaneous Research Associates Ltd.
Halifax Nova Scotia, B3H 1, Canada
Ultranova Skincare
Barrie Ontario, L4M 6, Canada
Lynderm Research Inc.
Markham Ontario, L3P 1, Canada
North Bay Dermatology Centre
North Bay Ontario, P1B 3, Canada
Oakville Dermatology Laser Centre
Oakville Ontario, L6J 7, Canada
Office of Dr. Michael Robern
Ottawa Ontario, K2G 6, Canada
K.Papp Clinical Research Inc.
Waterloo Ontario, N2J 1, Canada
CRCMRGilbert Inc., Centre de Dermatologie Maizerets
Quebec , G1J 1, Canada
Centro de Reumatologia y Ortopedia
Barranquilla Atlantico, 0000, Colombia
Riesgo de Fractura S.A
Bogot Cundinamarca, 0000, Colombia
Charite - Universitaetsmedizin Berlin
Berlin , 10117, Germany
Aerztehaus "Rudolf Virchow"
Berlin , 13055, Germany
Klinik und Poliklinik fuer Dermatologie und Allergologie der Universitaet Bonn
Bonn , 53105, Germany
Universitaetsklinik Carl Gustav Carus
Dresden , 01307, Germany
Klinische Forschung Hamburg GmbH
Hamburg , 20253, Germany
Universitaetsklinikum Schleswig-Holstein, Campus Kiel
Kiel , 24105, Germany
Universitaetsklinikum Muenster
Muenster , 48149, Germany
Klinische Forschung Schwerin GmbH
Schwerin , 19055, Germany
Praxisklinik fuer Dermatologie, Allergologie und Venenheilkunde
Vechta , 49377, Germany
Facharzt fuer Dermatologie und Venerologie, Allergologie
Wuppertal , 42275, Germany
Bacs-Kiskun Megyei Onkormanyzat Korhaza Szegedi Tudomanyegyetem AOK Oktato Korhaza
Kecskemet , 6000, Hungary
Josa Andras Oktatokorhaz, Borgyogyaszat
Nyiregyhaza , 4400, Hungary
Pecsi Tudomanyegyetem/Bor-, Nemikortani es Onkodermatologiai Klinika
Pecs , 7624, Hungary
Gunma University Hospital
Maebashi-shi Gunma, , Japan
JR Sapporo hospital
Sapporo Hokkaido, , Japan
Kobe University Hospital
Chuo-ku Kobe, , Japan
Kumamoto University Hospital
Kumamoto-shi Kumamoto, , Japan
Social Insurance Chuo General Hospital
Shinjyuku-ku Tokyo, , Japan
Centro de Dermatologia de Monterrey
Monterrey Nuevo Leon, 64460, Mexico
Poznanski Osrodek Medyczny
Poznan , 60-77, Poland
Katedra i Klinika Chorob Skornych i Wenerycznych, Pomorski Uniwersytet Medyczny
Szczecin , 70-11, Poland
Katedra i Klinika Dermatologii, Wenerologii i Alergologii Akademii Medycznej we Wroclawiu
Wroclaw , 50-36, Poland
Oddzial Dermatologiczny
Wroclaw , 51-12, Poland
Clinical Hospital Center Zvezdara
Belgrade , 11000, Serbia
National Cheng-Kung University Hospital
Tainan , 704, Taiwan
National Taiwan University Hospital
Taipei , 110, Taiwan
Dept of Dermatology and Venerology of SI "Crimean State Medical University n.a. S.I. Georgiyevskyj"
Simferopol Crimea, 95006, Ukraine
Dept of Dermatology, Infectious and Parasitic Skin Diseases
Kharkiv , 61057, Ukraine
Dept of Dermatology and Venereology of National Medical University n.a. O.O. Bogomolets
Kyiv , 01032, Ukraine
Ternopil Regional Clinical Dermatovenerologic Dispensary
Ternopil , 46006, Ukraine

How clear is this clinincal trial information?

Study is for people with:

Psoriasis

Phase:

Phase 3

Estimated Enrollment:

901

Study ID:

NCT01276639

Recruitment Status:

Completed

Sponsor:


Pfizer

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider